Amikacin and Cephalothin: Empiric Regimen for Granulocytopenic Cancer Patients

Amikacin (15 mg/kg per day) was used in combination with cephalothin (7 g/m(2) per day) as an empiric regimen for de novo febrile (>101°F [38.3°C]) episodes in 93 granulocytopenic (<1,000/mm(3)) cancer patients. Both drugs were given intravenously in four equal doses every 6 h. The response ra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Hahn, Davis M., Schimpff, Stephen C, Young, Viola Mae, Fortner, Clarence L., Standiford, Harold C., Wiernik, Peter H.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 1977
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC429987/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/335967/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.12.5.618
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares